Immunocore Holdings (IMCR) Earnings Date & Reports
Immunocore Holdings PLC is a commercial-stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMCR is expected to report earnings to rise 455.00% to -11 cents per share on November 11
Q3'26
Est.
$-0.11
Q2'26
Missed
by $0.03
Q1'26
Beat
by $0.52
Q4'25
Missed
by $0.40
Q3'25
Beat
by $0.24
The last earnings report on August 06 showed earnings per share of -1 cents, missing the estimate of 0 cents. With 161.25K shares outstanding, the current market capitalization sits at 1.90B.